HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact
Should breast cancer patients with low but not negative tumor expression of HER2 be considered a distinct patient group that can be treated differently from patients with tumors that are HER2 negative or HER2 positive? That was the question posed during a session at the recent San Antonio Breast Cancer Symposium (SABCS) 2022.Source: Medscape
Yale Cancer Center Study Characterizes Link Between Drug Resistance and Central Nervous System Relapse
A new study from Yale Cancer Center characterizes the functional link between drug resistance and central nervous system (CNS) relapse. The findings from a study led by Don Nguyen, PhD, BS, Associate Professor of Pathology and Medicine (Medical Oncology) and Assistant Yale Cancer Center Director for Research Development, were recently published in the journal Nature Communications.
Spatial and Single Cell Characterization of Breast Cancer Progression: Presenter Profile
Presentation is about methods for assessment of multiple molecular variables on a single piece of tissue to better understand breast cancer (or really any cancer) with respect to progression or response or resistance to specific therapies.Source: SABCS Meeting News
Cancer Research Institute To Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated By Ana Patricia Gámez, To Connect The U.S. Hispanic Cancer Community With Information That Can Save Lives
The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system's power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET. This free virtual event, moderated by TV Host and Entrepreneur Ana Patricia Gámez, and presented completely in Spanish, will connect Hispanic cancer patients and caregivers with groundbreaking research updates from leading immunotherapy experts driving scientific breakthroughs and advancements that impact patient care.Source: PR Newswire
Yale Cancer Center Researchers Awarded Grants by Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its 2022 research grants, including six funded grants at Yale Cancer Center and Smilow Cancer Hospital awarded to Mehra Golshan, MD, MBA, Melinda Irwin, PhD, MPH, Ian Krop, MD, PhD, Lajos Pusztai, MD, DPhil, David Rimm, MD, PhD, and Eric Winer, MD to support their research.
Rimm Lab Validates Objective Prognostic Marker in Patients With Early-stage Melanoma
An objective assessment of automated electronic tumor infiltrating lymphocytes percentage (eTILs%) scores is a strong prognostic marker in patients with early-stage melanoma. The study also identifies distinct TIL subpopulations that carry the prognostic values.
Dhanpat Jain, MD, Appointed to Cancer Committee of College of American Pathologists
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named to the Cancer Committee of the College of American Pathologists (CAP), the leading organization of board-certified pathologists that fosters and advocates excellence in the practice of pathology and laboratory medicine worldwide.
American Society for Investigative Pathology to Honor Qin Yan, PhD, with 2023 Outstanding Investigator Award
The American Society for Investigative Pathology has announced it will honor Qin Yan, PhD, Associate Professor of Pathology at Yale School of Medicine, with its 2023 Outstanding Investigator Award.
Manju Prasad, MD, MBBS, on Head and Neck Cancer Awareness Month
In recognition of Head and Neck Cancer Awareness Month, Manju Prasad, MD, MBBS, Professor of Pathology; Director, Endocrine Head and Neck Pathology Fellowship Program; Director, Endocrine Head and Neck Pathology, provides her insight.
Three Yale Cancer Center Trainees Receive Travel Awards to AACR Annual Meeting
The American Association for Cancer Research recently announced awards to support three young scientists from Yale Cancer Center to attend the 2022 Annual Meeting of the American Association for Cancer Research (AACR) in New Orleans from April 8 to 13.
Adebowale Adeniran, MD, on Kidney Cancer Awareness Month
In recognition of Kidney Cancer Awareness Month, Adebowale Adeniran, MD, Professor of Pathology; Director of Cytopathology; Director, Cytology Laboratory; Director, Anatomic Pathology Elective Program in Pathology, explains how Yale Pathologists work with Smilow Cancer Hospital oncologists to enhance patient care and provide the best course of treatment.
Joanna Gibson, MD, PhD, on Colorectal Cancer Awareness Month
In recognition of Colorectal Cancer Awareness Month, Joanna Gibson, MD, PhD, Associate Professor of Pathology and Director of Quality and Patient Safety at Yale Pathology, explains how Yale Pathologists collaborate with Smilow Cancer Hospital oncologists to determine the best therapeutic course for patients.
Dr. Aileen Fernandez Discusses Diversity Equity, and Inclusion with Shirley Malcolm of the American Association for the Advancement of Science
Aileen Fernandez, PhD, a Postdoctoral Fellow in the Department of Pathology at Yale School of Medicine, speaks with Shirley Malcolm, PhD, Senior Advisor to the Director of the American Association for the Advancement of Science and Director of its SEA Change initiative, which aims to advance institutional transformation in support of diversity, equity and inclusion, especially in colleges and universities.Source: YouTube
Officials Commend Partnership Among Yale Pathology, Yale School of Public Health and State Health Department to Expand SalivaDirect™ Testing at 2 New Haven Sites
Officials from the Yale Department of Pathology, the Yale School of Public Health and the Yale School of Medicine, along with Congresswoman Rosa DeLauro and Lt. Gov. Susan Bysiewicz, held a press conference Jan. 27 in New Haven’s Long Wharf to mark the opening of two free COVID-19 testing sites.
Chen Liu, MD, PhD, Leads Effort to Establish Institutional Biorepository at Yale School of Medicine
Chen Liu, MD, PhD, Chair of Yale Pathology, is leading an effort at Yale School of Medicine to establish an institutional biorepository for the coordinated collection of tissue, plasma, serum, and genetic samples, and clinical data using common processes and information systems.
Sanja Dacic, MD, PhD, Appointed Vice Chair and Director of Anatomic Pathology at Yale Pathology
Sanja Dacic, MD, PhD, an internationally renowned and highly accomplished leader in anatomic pathology, has been appointed Vice Chair and Director of Anatomic Pathology in the Department of Pathology at Yale School of Medicine, effective May 1, 2022.